• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

355
65
48
46
18

COUNTRY

45
12
5
5
5

PRICE

291
546
1,137
1,426

PUBLISHED

68
112
498
1,426

PRODUCT TYPE

1,329
67
17
13

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2014

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2014 Summary This, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2014’, provides an overview of the Secondary...

November 2014
FROM

Treatment Resistant Depression - Pipeline Review, H2 2014

Treatment Resistant Depression - Pipeline Review, H2 2014 Summary This, ‘Treatment Resistant Depression - Pipeline Review, H2 2014’, provides an overview of the Treatment Resistant Depression’s therapeutic...

November 2014
FROM

Brain Ischemia - Pipeline Review, H2 2014

Brain Ischemia - Pipeline Review, H2 2014 Summary This, ‘Brain Ischemia - Pipeline Review, H2 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Progressive Supranuclear Palsy - Pipeline Review, H2 2014

Progressive Supranuclear Palsy - Pipeline Review, H2 2014 Summary This, ‘Progressive Supranuclear Palsy - Pipeline Review, H2 2014’, provides an overview of the Progressive Supranuclear Palsy’s therapeutic...

November 2014
FROM

Encephalomyelitis - Pipeline Review, H2 2014

Encephalomyelitis - Pipeline Review, H2 2014 Summary This, ‘Encephalomyelitis - Pipeline Review, H2 2014’, provides an overview of the Encephalomyelitis’s therapeutic pipeline. This report provides...

November 2014
FROM
Ocular Pain - Pipeline Review, H2 2014 Ocular Pain - Pipeline Review, H2 2014 - Product Thumbnail Image

Ocular Pain - Pipeline Review, H2 2014

Ocular Pain - Pipeline Review, H2 2014 Summary This, ‘Ocular Pain - Pipeline Review, H2 2014’, provides an overview of the Ocular Pain’s therapeutic pipeline. This report provides comprehensive information...

November 2014
FROM
General Anxiety Disorder - Pipeline Review, H2 2014 General Anxiety Disorder - Pipeline Review, H2 2014 - Product Thumbnail Image

General Anxiety Disorder - Pipeline Review, H2 2014

General Anxiety Disorder - Pipeline Review, H2 2014 Summary This, ‘General Anxiety Disorder - Pipeline Review, H2 2014’, provides an overview of the General Anxiety Disorder’s therapeutic pipeline. This...

November 2014
FROM
Friedreich Ataxia - Pipeline Review, H2 2014 Friedreich Ataxia - Pipeline Review, H2 2014 - Product Thumbnail Image

Friedreich Ataxia - Pipeline Review, H2 2014

Friedreich Ataxia - Pipeline Review, H2 2014 Summary This, ‘Friedreich Ataxia - Pipeline Review, H2 2014’, provides an overview of the Friedreich Ataxia’s therapeutic pipeline. This report provides...

November 2014
FROM
Memory Impairment - Pipeline Review, H2 2014 Memory Impairment - Pipeline Review, H2 2014 - Product Thumbnail Image

Memory Impairment - Pipeline Review, H2 2014

Memory Impairment - Pipeline Review, H2 2014 Summary This, ‘Memory Impairment - Pipeline Review, H2 2014’, provides an overview of the Memory Impairment’s therapeutic pipeline. This report provides...

November 2014
FROM
Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014 Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014 - Product Thumbnail Image

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2014 Summary This, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2014’, provides an overview of the Neuromyelitis Optica...

November 2014
FROM
Ischemic Cerebral Stroke - Pipeline Review, H2 2014 Ischemic Cerebral Stroke - Pipeline Review, H2 2014 - Product Thumbnail Image

Ischemic Cerebral Stroke - Pipeline Review, H2 2014

Ischemic Cerebral Stroke - Pipeline Review, H2 2014 Summary This, ‘Ischemic Cerebral Stroke - Pipeline Review, H2 2014’, provides an overview of the Ischemic Cerebral Stroke’s therapeutic pipeline. This...

November 2014
FROM
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014 Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014 - Product Thumbnail Image

Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014

Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014 Summary This, ‘Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014’, provides an overview of the Cerebral Infarction...

November 2014
FROM
Central Nervous System Disorders Pipeline Highlights Database - 2015 Central Nervous System Disorders Pipeline Highlights Database - 2015 - Product Thumbnail Image

Central Nervous System Disorders Pipeline Highlights Database - 2015

Central Nervous System Disorders Pipeline Highlights Database – 2015, provides most up-to-date information on key pipeline molecules in the global Central Nervous System (CNS) disorders Drug market....

November 2014
FROM

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020

Summary: This report provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides...

October 2014
FROM

Insomnia - Pipeline Review, H2 2014

Insomnia - Pipeline Review, H2 2014 Summary This, ‘Insomnia - Pipeline Review, H2 2014’, provides an overview of the Insomnia’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Depression - Pipeline Review, H2 2014

Depression - Pipeline Review, H2 2014 Summary This, ‘Depression - Pipeline Review, H2 2014’, provides an overview of the Depression’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Alcohol Addiction - Pipeline Review, H2 2014

Alcohol Addiction - Pipeline Review, H2 2014 Summary This, ‘Alcohol Addiction - Pipeline Review, H2 2014’, provides an overview of the Alcohol Addiction’s therapeutic pipeline. This report provides...

October 2014
FROM

Smoking Cessation - Pipeline Review, H2 2014

Smoking Cessation - Pipeline Review, H2 2014 Summary This, ‘Smoking Cessation - Pipeline Review, H2 2014’, provides an overview of the Smoking Cessation’s therapeutic pipeline. This report provides...

October 2014
FROM

Ischemic Stroke - Pipeline Review, H2 2014

Ischemic Stroke - Pipeline Review, H2 2014 Summary This, ‘Ischemic Stroke - Pipeline Review, H2 2014’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.